Tumor-reactive T helper cells in the context of vaccination against glioma

With the advances in immunogenomics, the majority of tumor-specific antigens were found to be recognized by T helper cells (THCs). This observation led to the development of long epitope vaccines in various cancers. Mechanistically, we are still gaining a deeper understanding of the mode of action o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Zhao, Binghao (VerfasserIn) , Kilian, Michael (VerfasserIn) , Bunse, Theresa (VerfasserIn) , Platten, Michael (VerfasserIn) , Bunse, Lukas (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 13 November 2023
In: Cancer cell
Year: 2023, Jahrgang: 41, Heft: 11, Pages: 1829-1834
ISSN:1878-3686
DOI:10.1016/j.ccell.2023.09.013
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.ccell.2023.09.013
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S153561082300329X
Volltext
Verfasserangaben:Binghao Zhao, Michael Kilian, Theresa Bunse, Michael Platten and Lukas Bunse
Beschreibung
Zusammenfassung:With the advances in immunogenomics, the majority of tumor-specific antigens were found to be recognized by T helper cells (THCs). This observation led to the development of long epitope vaccines in various cancers. Mechanistically, we are still gaining a deeper understanding of the mode of action of THCs as precision antitumor agonists. Here, we discuss the specific cellular mechanisms of THC functions in glioma immunology and contextualize current advances in anti-glioma vaccination exploiting THCs.
Beschreibung:Online verfügbar: 19. Oktober 2023, Artikelversion: 13. November 2023
Gesehen am 07.05.2024
Beschreibung:Online Resource
ISSN:1878-3686
DOI:10.1016/j.ccell.2023.09.013